OCUL
Ocular Therapeutix, Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
+2.82%
vs ±13.6% implied · ×0.21
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $322.5M | 15.66% | +0.58% | |
| 2 | Deep Track CapitalDeep Track Capital | $193.3M | 9.38% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $190.3M | 9.24% | +20.11% | |
| 4 | venBio Select AdvisorvenBio Select Advisor | $123.1M | 5.98% | +1.83% | |
| 5 | Summer RoadSummer Road | $119.9M | 5.82% | +2.76% | |
| 6 | VR AdviserVR Adviser | $101.6M | 4.93% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $86.7M | 4.21% | +1.30% | |
| 8 | T. Rowe Price AssociatesT. Rowe Price | $74.9M | 3.63% | +29.27% | |
| 9 | Logos Global ManagementLogos Global | $52.0M | 2.53% | +37.66% | |
| 10 | State StreetState Streetindex-like | $51.4M | 2.49% | +11.15% | |
| 11 | Geode Capital ManagementGeodeindex-like | $49.3M | 2.39% | +10.86% | |
| 12 | Point72 Asset ManagementPoint72 | $32.3M | 1.57% | −40.52% | |
| 13 | Balyasny Asset ManagementBalyasny | $31.9M | 1.55% | +20.55% | |
| 14 | Dimensional Fund AdvisorsDimensional | $27.3M | 1.33% | +328.37% | |
| 15 | Deltec Asset ManagementDeltec | $24.3M | 1.18% | +5.79% | |
| 16 | Octagon Capital AdvisorsOctagon Capital | $20.4M | 0.99% | −34.47% | |
| 17 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $19.4M | 0.94% | +23.73% | |
| 18 | Northern TrustNorthern Trustindex-like | $17.7M | 0.86% | +17.95% | |
| 19 | Goldman Sachs GroupGoldman Sachs | $17.3M | 0.84% | +58.66% | |
| 20 | NuveenNuveenindex-like | $16.7M | 0.81% | +312.88% | |
| 21 | Woodline PartnersWoodline Partners | $16.4M | 0.79% | 0.00% | |
| 22 | TCG Crossover ManagementTCG Crossover | $16.2M | 0.79% | 0.00% | |
| 23 | UBS GroupUBS | $15.2M | 0.74% | +2.00% | |
| 24 | Adage Capital Partners GPAdage Capital Partners GP | $15.2M | 0.74% | new | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $15.1M | 0.73% | +4.95% |
263 managers report $2.1B of Ocular Therapeutix on form 13F for the quarter ended Jun 30 '26. 25 of them hold 80% of it; FMR is largest at 15.66%.
Ocular Therapeutix, Inc
6.98
−0.33 · −4.54%
post 6.98 −0.01%
Expected move
Inputs8Q avg ±6.3%·×0.71·cheap
straddle ±14.6%
spot 6.97exp Nov 20ATM strike 7ATM straddle 1.20IV 90%